Product Information
PAROXETINE ER 25 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.4211 per EA under NDC 68180064606. Its NADAC has been published 433 times since Mar 22, 2017.
Strength
25 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180064606
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/18/2025
Active Ingredients
PAROXETINE HYDROCHLORIDE HEMIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA204134On Market Since
3/6/2017
Pharmacological Classes
Price Statistics
The NADAC for PAROXETINE ER 25 MG TABLET has been published 433 times since Mar 22, 2017, and over the history we have for it it has declined 89.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4211 per EA |
|---|---|
| All-time high | $3.9200 (Apr 12, 2017) |
| All-time low | $0.3584 (Nov 20, 2024) |
| 52-week high | $0.4211 |
| 52-week low | $0.4211 |
| Median price | $1.0758 |
| Average price | $1.4382 |
| Largest weekly change | +53.5% (Jul 19, 2023) |
| Weeks tracked | 433 |
| Tracking since | Mar 22, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the PAROXETINE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PAROXETINE ER 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE ER 25 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.4211 per EA (NDC 68180064606), effective Jul 2, 2025.
How has the price of PAROXETINE ER 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAROXETINE ER 25 MG TABLET has declined 89.3%. It has been tracked across 433 weekly CMS publications since Mar 22, 2017.
What are the highest and lowest recorded NADAC prices for PAROXETINE ER 25 MG TABLET?
Since Mar 22, 2017, the NADAC for PAROXETINE ER 25 MG TABLET has ranged from a low of $0.3584 (Nov 20, 2024) to a high of $3.9200 (Apr 12, 2017), with a median of $1.0758 per EA.
Are there cheaper alternatives to PAROXETINE ER 25 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PAROXETINE ER 25 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures PAROXETINE ER 25 MG TABLET?
PAROXETINE ER 25 MG TABLET (NDC 68180064606) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification